Skip to main content
Veterinary Medicines

Dicortineff-Vet (2500 j.m. + 25 j.m. + 1 mg)/ml Krople do oczu i uszu, zawiesina

Authorised
  • Fludrocortisone acetate
  • Gramicidin
  • NEOMYCIN SULFATE

Product identification

Medicine name:
Dicortineff-Vet (2500 j.m. + 25 j.m. + 1 mg)/ml Krople do oczu i uszu, zawiesina
Active substance:
  • Fludrocortisone acetate
  • Gramicidin
  • NEOMYCIN SULFATE
Target species:
  • Cat
  • Dog
Route of administration:
  • Auricular use
  • Ocular use

Product details

Active substance and strength:
  • Fludrocortisone acetate
    1.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Gramicidin
    25.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • NEOMYCIN SULFATE
    2500.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Ear/eye drops, suspension
Withdrawal period by route of administration:
  • Auricular use
    • Cat
    • Dog
  • Ocular use
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QS03CA05
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0346
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 16/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."